**Executive Summary**
A Genome-Wide Association Study (GWAS) by the Centre for Cancer Epidemiology (CCE) at Tata Memorial Centre (TMC) has identified key genetic factors influencing the early development of oral cancer in Indian tobacco chewers, with findings presented at a TMC press conference. The study, published in eBioMedicine, highlights specific genetic markers increasing susceptibility to oral cavity cancer and emphasizes the importance of considering both genetic predisposition and tobacco-chewing habits for personalized screening strategies. The study took place on November 29, 2025.
**Key Points / Main Content**
* **Study Findings:**
* Identified genetic factors that explain why some tobacco chewers develop oral cancer nearly a decade earlier.
* Identified specific genetic markers that significantly increase susceptibility to oral cavity cancer.
* Tobacco chewing remains the most preventable cause, but genetic susceptibility markers double the risk for individuals with a high genetic risk score.
* Identified significant genetic risk loci on chromosomes 5 and 6, near genes including CLPTM1L-TERT, HLA-DRB1, HLA-DQB1, and CEP43 and novel risk loci near the NOTCH1 gene.
* Tobacco chewers with a high polygenic risk score developed Buccal Mucosa cancer 10 years earlier.
* **Expert Opinions:**
* Dr. Sudeep Gupta: Emphasized the need to examine gene-environment interactions and develop polygenic risk scores.
* Dr. Pankaj Chaturvedi: Reiterated that tobacco chewing is a major risk factor, with tobacco chewers having 26 times higher risk.
* Dr. Elisabete Weiderpass: Highlighted the significance of the study in understanding genetic and environmental factors driving buccal mucosa cancer.
* Dr. Rajesh Dikshit: Explained that understanding genetic predisposition can help predict oral cavity cancer development and CCE is conducting GWAS research on other common cancers in India.
* Dr. Nilanjan Chatterjee: Emphasized the importance of choosing habits that keep this cancer at bay.
* Dr. Sharayu Mhatre: Stated that while tobacco use remains the strongest risk factor, a genetic susceptibility component also plays a role.
* Dr. Preetha Rajaraman: Remarked on the insights into how behaviour interacts with genetic makeup to influence buccal mucosa cancer risk.
* Dr. Siddhartha Kar: Stated that the study lays the groundwork for targeted prevention and early detection.
* **Indian Scenario:**
* India records approximately 141,342 cases of oral cancer annually.
* The study demonstrates that genetic makeup plays a crucial role in elevating oral cancer risk among tobacco chewers.
* **Study Methodology**
* The study compared 2,160 cases of Buccal Mucosa cancer with 2,325 controls from various regions in India and conducted a genome-wide scan to assess genetic susceptibility.
**Impact Analysis**
**Stakeholder: Tobacco Chewers**
* **Impact:** Increased awareness of genetic predisposition to oral cancer and the amplified risk when combined with tobacco use.
* **Action Required:** Consider genetic screening and focus on tobacco cessation to mitigate risk.
**Stakeholder: Researchers/Medical Professionals**
* **Impact:** Gained insights into genetic factors driving oral cancer, paving the way for targeted prevention and personalized screening strategies.
* **Action Required:** Further exploration of identified pathways and development of precise early detection methods. Conduct further GWAS research.
**Stakeholder: Public Health Organizations**
* **Impact:** Need for tailored prevention and screening strategies for high-risk populations, considering both genetic susceptibility and tobacco-chewing habits.
* **Action Required:** Implement targeted prevention programs and screening initiatives based on study findings.
**Stakeholder: General Public (India/South Asia)**
* **Impact:** Increased understanding of the genetic and environmental factors driving buccal mucosa cancer, highlighting the heavy burden of the disease.
* **Action Required:** Awareness of the link between tobacco chewing, genetic predisposition, and oral cancer risk.
Key Entities Referenced
Tata Memorial Centre (TMC): A cancer research institute in Mumbai, India, where the Genome-Wide Association Study (GWAS) was conducted.
Centre for Cancer Epidemiology (CCE): The organization that conducted the Genome-Wide Association Study (GWAS) at the Tata Memorial Centre (TMC).
Genome-Wide Association Study (GWAS): A research study that identifies genetic factors explaining why some tobacco chewers in India develop oral cancer earlier than others.
Ministry of Health and Family Welfare: The Indian ministry overseeing the health sector and responsible for public health initiatives.
India: The country where the study was conducted and the primary focus of the research.
Ministry of Health and Family Welfare
New Genome-Wide Study from Tata Memorial
Centre Reveals: “Why Do Some Tobacco
Chewers Develop Oral Cancer Early?”
प्रव तथ: 29 NOV 2025 3:46PM by PIB Mumbai
Mumbai, 29 November 2025
A landmark Genome-Wide Association Study (GWAS) conducted by the Centre for
Cancer Epidemiology (CCE), ACTREC at the Tata Memorial Centre (TMC), Mumbai,
has identified key genetic factors that explain why some tobacco chewers in India
develop oral cancer nearly a decade earlier than others. The findings were shared
during a press conference held at TMC on Saturday, where the team of expert
doctors involved in the research presented the study in detail.
The new research, published in eBioMedicine, part of The Lancet Discovery Science,
identifies specific genetic markers that significantly increase susceptibility to oral
cavity cancer—one of the most common and preventable cancers in India, primarily
linked to tobacco use.
Dr. Sudeep Gupta, Director, Tata Memorial Centre, underscored the need to examine
gene–environment interactions and to develop polygenic risk scores for common
cancers in India. He emphasized that although genetic susceptibility is important to
understand, tobacco chewing remains the single most preventable cause of oral
cancer, with more than 80% of cases potentially avoidable through effective tobacco
control policies.
Dr. Pankaj Chaturvedi, Director, ACTREC, reiterated that tobacco chewing is a major
risk factor for oral cancers, noting that the risk of developing oral cancer is 26 times
higher among tobacco chewers compared to non-users. He added that genetic
susceptibility markers further double the risk among individuals with a high genetic
risk score.
Dr. Elisabete Weiderpass, Director of the International Agency for Research on
Cancer (IARC), WHO, Lyon, France, highlighted the significance of the study,
stating:
“This landmark study represents a significant advance in our understanding of the
genetic and environmental factors driving buccal mucosa cancer, a disease that
imposes a heavy burden in India and across South Asia. By conducting the largest
genome-wide association study of its kind and integrating data from multiple
ancestries, the authors have identified novel risk loci and illuminated the complexinterplay between genetic susceptibility and tobacco chewing. These findings deepen
our knowledge of oral cancer etiology and highlight the urgent need for tailored
prevention and screening strategies for high-risk populations.”
Dr. Rajesh Dikshit, Director, CCE, explained that understanding genetic
predisposition can help predict oral cavity cancer development among tobacco
chewers. He noted that pathway analysis from the study identified distinct immune
pathways and “highly calcium-permeable nicotine receptor-encoding genes” as
being involved in cancer development. Further exploration of these pathways could
lead to more precise methods for early detection and prevention.
Dr. Nilanjan Chatterjee, Bloomberg Distinguished Professor, Johns Hopkins
University, said:
“This article provides important insights into the genes that influence susceptibility
to this cancer and how they interact with the carcinogenic effects of tobacco
chewing. Individuals who chew tobacco face a substantially higher risk of developing
buccal mucosa cancer. What is often less recognized is that genetic predisposition
can further amplify this risk. We don’t get to choose the genes we’re born with,
which makes it even more important to choose the habits that keep this cancer at
bay.”
Dr. Sharayu Mhatre, Scientific Officer, CCE, and lead author of the study, stated that
while tobacco use remains the strongest risk factor for Buccal Mucosa cancer, a
genetic susceptibility component also plays a role. She noted a 24% relative excess
of oral cavity cancer cases among tobacco chewers with a high genetic risk score
compared to those with a low score. Comparisons with European populations
showed both similarities and distinct differences in genetic architecture,
underscoring the importance of India-specific genetic data.
Dr. Preetha Rajaraman, Executive Director (U.S.), Vice Chair, and Chief of Research,
Radiation Effects Research Foundation (RERF), Hiroshima, remarked that the
findings provide important insights into how behaviour interacts with genetic
makeup to influence buccal mucosa cancer risk. She emphasized the potential for
more personalized screening strategies by considering both tobacco-chewing habits
and genetic predisposition.
Dr. Siddhartha Kar, Associate Professor, Oncology Department, Cambridge
University, added:
“This landmark study advances our understanding of why oral cancer is so common
in India, uncovering uniquely Indian genetic risk factors. By showing how inherited
risk interacts with tobacco use, it lays the groundwork for targeted prevention and
early detection.”
Dr. Rajesh Dikshit further shared that CCE is conducting GWAS research on several
other common cancers in India, which will help develop genetic risk scores for those
cancers as well. Dr. Sharayu Mhatre presented the study results and emphasized the
need for large sample sizes to better understand genetic factors responsible for
cancer causation.
How the Study Was ConductedThe study compared 2,160 cases of Buccal Mucosa cancer with 2,325 controls from
various regions in India and conducted a genome-wide scan to assess genetic
susceptibility. Researchers identified significant genetic risk loci on chromosomes 5
and 6, near genes including CLPTM1L-TERT, HLA-DRB1, HLA-DQB1, and CEP43. A
meta-analysis incorporating data from Europe and Taiwan also identified novel risk
loci near the NOTCH1 gene.
The investigators calculated a polygenic risk score and found that tobacco chewers
with a high score developed Buccal Mucosa cancer 10 years earlier than those with
a low score.
The Indian Scenario
India records approximately 141,342 cases of oral cancer, with an average age-
standardized incidence rate of 10.0 per 100,000 population. In certain states, this
rate rises to 25–33 per 100,000. Despite similar lifestyle factors, the onset and
progression of the disease vary significantly among individuals. This study provides
the first clear genetic explanation for these variations, demonstrating that genetic
makeup plays a crucial role in elevating oral cancer risk among tobacco chewers.
Click here for Frequently asked questions
***
Saurabh Khekde/Parshuram Kor
Follow us on social media: @PIBMumbai /PIBMumbai /pibmumbai pibmumbai[at]gmail[dot]com /PI
BMumbai /pibmumbai
(रलीज़ आईडी: 2196291) आगंतुक पटल : 1164
इस वज्ञ को इन भाषाओ ंम पढ़: Marathi